Liver transplantation in patients with cystic fibrosis: Analysis of united network for organ sharing data

Liver Transplantation

Volumn 17, Issue 3, 2011, Pages 243-250

  Mendizabal, Manuel ^a,b   Reddy, K Rajender ^b   Cassuto, James ^c   Olthoff, Kim M ^c   Faust, Thomas W ^b   Makar, George A ^b   Rand, Elizabeth B ^d   Shaked, Abraham ^c   Abt, Peter L ^c  

^a UNIVERSIDAD AUSTRAL   (Argentina)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHILD; CYSTIC FIBROSIS; DATA BASE; FEMALE; GRAFT RECIPIENT; HUMAN; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL TIME;

ADOLESCENT; ADULT; CHI-SQUARE DISTRIBUTION; CHILD; CYSTIC FIBROSIS; END STAGE LIVER DISEASE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; UNITED STATES; WAITING LISTS; YOUNG ADULT;

EID: 79952396956     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22240     Document Type: Article

References (27)

1. Rowe SM, Miller S, Sorscher EJ., Cystic fibrosis. N Engl J Med 2005; 352: 1992-2001. (Pubitemid 40638370)
2. Colombo C, Battezzati PM, Crosignani A, Morabito A, Costantini D, Padoan R, Giunta A., Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. HEPATOLOGY 2002; 36: 1374-1382. (Pubitemid 35403528)
3. Lindblad A, Glaumann H, Strandvik B., Natural history of liver disease in cystic fibrosis. HEPATOLOGY 1999; 30: 1151-1158. (Pubitemid 29510852)
4. Nash KL, Allison ME, McKeon D, Lomas DJ, Haworth CS, Bilton D, Alexander GJ., A single centre experience of liver disease in adults with cystic fibrosis 1995-2006. J Cyst Fibros 2008; 7: 252-257.
5. Davis PB., Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006; 173: 475-482.
6. Arkwright PD, Pravica V, Geraghty PJ, Super M, Webb AK, Schwarz M, Hutchinson IV., End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms. Am J Respir Crit Care Med 2003; 167: 384-389. (Pubitemid 36216420)
7. Gabolde M, Hubert D, Guilloud-Bataille M, Lenaerts C, Feingold J, Besmond C., The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis. J Med Genet 2001; 38: 310-311. (Pubitemid 32433983)
8. Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, et al. Genetic modifiers of liver disease in cystic fibrosis. JAMA 2009; 302: 1076-1083.
9. Wilschanski M, Durie PR., Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 2007; 56: 1153-1163. (Pubitemid 47123248)
10. Lindblad A, Glaumann H, Strandvik B., A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. HEPATOLOGY 1998; 27: 166-174. (Pubitemid 28041550)
11. Desmond CP, Wilson J, Bailey M, Clark D, Roberts SK., The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid. Liver Int 2007; 27: 1402-1408. (Pubitemid 350142255)
12. Fridell JA, Bond GJ, Mazariegos GV, Orenstein DM, Jain A, Sindhi R, et al. Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center's experience. J Pediatr Surg 2003; 38: 1152-1156. (Pubitemid 37048033)
13. Melzi ML, Kelly DA, Colombo C, Jara P, Manzanares J, Colledan M, et al. Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry. Transpl Int 2006; 19: 726-731. (Pubitemid 44196161)
14. Nash KL, Collier JD, French J, McKeon D, Gimson AE, Jamieson NV, et al. Cystic fibrosis liver disease: to transplant or not to transplant ? Am J Transplant 2008; 8: 162-169.
15. Colombo C, Costantini D, Rocchi A, Romano G, Rossi G, Bianchi ML, et al. Effects of liver transplantation on the nutritional status of patients with cystic fibrosis. Transpl Int 2005; 18: 246-255. (Pubitemid 41743317)
16. Milkiewicz P, Skiba G, Kelly D, Weller P, Bonser R, Gur U, et al. Transplantation for cystic fibrosis: outcome following early liver transplantation. J Gastroenterol Hepatol 2002; 17: 208-213. (Pubitemid 34415676)
17. Couetil JP, Soubrane O, Houssin DP, Dousset BE, Chevalier PG, Guinvarch A, et al. Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children. Transpl Int 1997; 10: 33-39. (Pubitemid 26413388)
18. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790. (Pubitemid 43345017)
19. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA., The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-313. (Pubitemid 40179517)
20. Ikegami T, Sanchez EQ, Uemura T, Narasimhan G, Masannat O, Chinnakotla S, et al. Liver transplantation for cystic fibrosis in adults. Surg Today 2008; 38: 26-29. (Pubitemid 350292599)
21. Noble-Jamieson G, Barnes N, Jamieson N, Friend P, Calne R., Liver transplantation for hepatic cirrhosis in cystic fibrosis. J R Soc Med 1996; 89 (suppl 27): 31-37.
22. Mackie AD, Thornton SJ, Edenborough FP., Cystic fibrosis-related diabetes. Diabet Med 2003; 20: 425-436. (Pubitemid 36776001)
23. Mekeel KL, Langham MR Jr, Gonzalez-Perralta R, Reed A, Hemming AW., Combined en bloc liver pancreas transplantation for children with CF. Liver Transpl 2007; 13: 406-409. (Pubitemid 46444470)
24. Horslen S, Sweet S, Gish RG, Shepherd R., Model for End-Stage Liver Disease (MELD) exception for cystic fibrosis. Liver Transpl 2006; 12 (suppl 3): S98-S99. (Pubitemid 44911781)
25. Samuelson AL, Lee M, Kamal A, Keeffe EB, Ahmed A., Diabetes mellitus increases the risk of mortality following liver transplantation independent of MELD score. Dig Dis Sci 2010; 55: 2089-2094.
26. Brennan AL, Geddes DM, Gyi KM, Baker EH., Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 2004; 3: 209-222. (Pubitemid 40227489)
27. Rosenecker J, Hofler R, Steinkamp G, Eichler I, Smaczny C, Ballmann M, et al. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 2001; 6: 345-350.